Skip to main content

Building the next generation of biotech ventures

Welcome to BaseLaunch

We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures developing cutting-edge therapeutics. And we know how to do this – so far our portfolio has raised over $600M in financing with an average first VC round of over $28M per company.

Money dollar Icon png

Up to $500,000
in financing

Access to our partners,
global biopharma & investors

Company & team
build out

Access to labs &
related infrastructure
where needed


We are very pleased to continue our commitment to BaseLaunch. Basel has always been home to great ideas and innovation and today it is a leading life sciences hub within Switzerland and globally.

James SabryGlobal Head of Roche Pharma Partnering

We are delighted to join BaseLaunch as a partner in the next phase of its company building activities. The Pureos team worked closely with BaseLaunch during the Series A funding of Alentis Therapeutics and has been very impressed by the team and the quality of the selected programs.

Klaus Breiner, PhDManaging Partner at Pureos Bioventures

In joining BaseLaunch, centered in the Basel Area, a major hub for life sciences innovation in Europe, our team is very excited to explore new opportunities of discovering promising therapeutic ventures and supporting exceptional seed-stage biotech companies developing sciences into novel therapeutics.

James LeeCEO at Bridge Biotherapeutics

This partnership will help us identify and build relationships with potential external collaborators from throughout Europe…

Dr. Adrian ZuercherVice President, Research Europe and Head of Plasma Protein Research, CSL Behring

Incubators and accelerators are central to the global healthcare start-up ecosystem. We have been collaborating with BaseLaunch since launch in supporting the growth and development of early-stage biotech ventures and recognize the contribution the team has made towards achieving their goals...

Nerida ScottHead, Johnson & Johnson Innovation

CMS is delighted to be part of BaseLaunch, giving us the opportunity to meet and support truly innovative companies linked to one of the preeminent centres globally for healthcare R&D.

James StearnsCIO (Europe & Americas), China Medical System Holdings

With our involvement in the review process and funding decisions through our investment board seat, we aim to contribute to BaseLaunch‘s company creation track record and leverage AbbVie‘s expertise in translating innovative science into novel therapeutics.

Christian SchubertVice President and Head of AbbVie Ventures, Cambridge, MA

Application cycle is now open!

The next deadline is 4 September 2024

Sign up for our newsletter

Quarterly insights from our vibrant biotech ecosystem